Vaccitech Analyst Ratings
Vaccitech Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/25/2023 | 93.45% | Morgan Stanley | $14 → $3.25 | Downgrades | Overweight → Equal-Weight |
| 08/18/2023 | 733.33% | Morgan Stanley | $15 → $14 | Maintains | Overweight |
| 06/13/2023 | 792.86% | HC Wainwright & Co. | → $15 | Reiterates | Buy → Buy |
| 05/16/2023 | 792.86% | Morgan Stanley | $16 → $15 | Maintains | Overweight |
| 03/29/2023 | 792.86% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 03/27/2023 | 792.86% | HC Wainwright & Co. | $20 → $15 | Maintains | Buy |
| 03/21/2023 | 1090.48% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
| 08/15/2022 | 852.38% | Morgan Stanley | $19 → $16 | Maintains | Overweight |
| 08/11/2022 | 1090.48% | HC Wainwright & Co. | $22 → $20 | Maintains | Buy |
| 05/17/2022 | 1030.95% | Morgan Stanley | $20 → $19 | Maintains | Overweight |
| 05/13/2022 | 1209.52% | HC Wainwright & Co. | $23 → $22 | Maintains | Buy |
| 12/15/2021 | 1269.05% | HC Wainwright & Co. | $25 → $23 | Maintains | Buy |
| 05/25/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 05/25/2021 | 1566.67% | Jefferies | → $28 | Initiates Coverage On | → Buy |
| 05/25/2021 | 1209.52% | Morgan Stanley | → $22 | Initiates Coverage On | → Overweight |
| 05/24/2021 | 1388.1% | HC Wainwright & Co. | → $25 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/25/2023 | 93.45% | 摩根士丹利 | $14→$3.25 | 評級下調 | 超重→等重 |
| 2023年08月18日 | 733.33% | 摩根士丹利 | $15→$14 | 維護 | 超重 |
| 2023/06/13 | 792.86% | HC Wainwright公司 | →$15 | 重申 | 購買→購買 |
| 2023年05月16日 | 792.86% | 摩根士丹利 | $16→$15 | 維護 | 超重 |
| 03/29/2023 | 792.86% | HC Wainwright公司 | →$15 | 重申 | →購買 |
| 03/27/2023 | 792.86% | HC Wainwright公司 | $20→$15 | 維護 | 買 |
| 03/21/2023 | 1090.48% | HC Wainwright公司 | →$20 | 重申 | →購買 |
| 2022年08月15日 | 852.38% | 摩根士丹利 | $19→$16 | 維護 | 超重 |
| 2022年08月11日 | 1090.48% | HC Wainwright公司 | $22→$20 | 維護 | 買 |
| 2022/05/17 | 1030.95% | 摩根士丹利 | $20→$19 | 維護 | 超重 |
| 2022年05月13日 | 1209.52% | HC Wainwright公司 | $23→$22 | 維護 | 買 |
| 2021年12月15日 | 1269.05% | HC Wainwright公司 | $25→$23 | 維護 | 買 |
| 2021/05/25 | - | 威廉·布萊爾 | 開始承保 | →跑贏大盤 | |
| 2021/05/25 | 1566.67% | 傑富瑞 | →$28 | 開始承保 | →購買 |
| 2021/05/25 | 1209.52% | 摩根士丹利 | →$22 | 開始承保 | →超重 |
| 2021/05/24 | 1388.1% | HC Wainwright公司 | →$25 | 開始承保 | →購買 |
What is the target price for Vaccitech (VACC)?
Vaccitech(VACC)的目標價是多少？
The latest price target for Vaccitech (NASDAQ: VACC) was reported by Morgan Stanley on September 25, 2023. The analyst firm set a price target for $3.25 expecting VACC to rise to within 12 months (a possible 93.45% upside). 7 analyst firms have reported ratings in the last year.
高科(納斯達克代碼：VACC)的最新目標價是由摩根士丹利於2023年9月25日報道的。這家分析公司將目標價定為3.25美元，預計VACC將在12個月內升至(可能上漲93.45%)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Vaccitech (VACC)?
Vaccitech(VACC)的最新分析師評級是多少？
The latest analyst rating for Vaccitech (NASDAQ: VACC) was provided by Morgan Stanley, and Vaccitech downgraded their equal-weight rating.
納斯達克(Sequoia Capital：VACC)最新分析師評級由摩根士丹利提供，華為下調了兩家公司的同等權重評級。
When is the next analyst rating going to be posted or updated for Vaccitech (VACC)?
Vaccitech(VACC)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaccitech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaccitech was filed on September 25, 2023 so you should expect the next rating to be made available sometime around September 25, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Vaccitech的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。對Vaccitech的上一次評級是在2023年9月25日提交的，因此您應該預計下一次評級將在2024年9月25日左右提供。
Is the Analyst Rating Vaccitech (VACC) correct?
分析師對Vaccitech的評級正確嗎？
While ratings are subjective and will change, the latest Vaccitech (VACC) rating was a downgraded with a price target of $14.00 to $3.25. The current price Vaccitech (VACC) is trading at is $1.68, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Vaccitech(VACC)評級被下調，目標價為14.00美元至3.25美元。Vaccitech(VACC)目前的交易價格為1.68美元，超出了分析師的預測區間。